ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2022

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions
Focal Epilepsy
Interventions
DRUG

ENX-101

Adjunctive treatment to current antiseizure medication

Trial Locations (38)

10016

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York

10467

Montefiore Medical Center, The Bronx

14618

University of Rochester, Rochester

15213

University of Pittsburgh, Pittsburgh

20817

Mid-Atlantic Epilepsy and Sleep Center, Bethesda

21201

University of Maryland Medical Center, Baltimore

22908

University of Virginia, Charlottesville

27710

Duke University School of Medicine, Durham

28204

Atrium Health, Chapel Hill

29732

DJL Clinical Research, Rock Hill

30322

Emory University School of Medicine, Atlanta

32611

University of Florida Research Institute of Orlando, Gainesville

32803

Florida Hospital, Orlando

32825

Comprehensive Neurology Clinic, Orlando

33032

Royal Care Medical Research Corporation, Miami

33136

University of Miami, Miami

33155

D&H National Research Centers, Miami

S&G Research Center Corp., Miami

40504

Saint Joseph Health System, Lexington

42101

Thomas Jefferson University, Philadelphia

44718

NeuroScience Research Center, LLC, Canton

48109

University of Michigan, Ann Arbor

48170

SRI International, Plymouth

48334

Oakland University William Beaumont School of Medicine, Farmington Hills

61603

OSF HealthCare Illinois Neurological Institute, Peoria

63044

Advanced Clinical Research Center, Bridgeton

63110

Washington University School of Medicine, St Louis

66160

University of Kansas, Kansas City

68510

Somnos Clinical Research/Neurology Associates, Lincoln

77479

Mt. Olympus Medical Research, Sugar Land

80045

University of Colorado, Aurora

85013

Barrow Neurological Institute, Phoenix

85724

University of Arizona, Tucson

90242

Rancho Research Institute at Rancho Los Amigos National Rehabilitation Center, Downey

96817

Hawaii Pacific Neuroscience, Honolulu

04074

Maine Medical Partners Neurology, Scarborough

07601

Northeast Regional Epilepsy Group, Hackensack

07039

Institute of Neurology and Neurosurgery at Saint Barnabas LLC, Livingston

Sponsors
All Listed Sponsors
lead

Engrail Therapeutics INC

INDUSTRY

NCT05481905 - ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures | Biotech Hunter | Biotech Hunter